<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Novacyt shares jump 45% following FDA approval for COVID-19 tests	</title>
	<atom:link href="https://ukinvestor.foxrobinson.com/novacyt-shares-jump-45-following-fda-approval-for-covid-19-tests/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestor.foxrobinson.com/novacyt-shares-jump-45-following-fda-approval-for-covid-19-tests/</link>
	<description></description>
	<lastBuildDate>Wed, 01 Apr 2020 13:29:57 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.6.3</generator>
	<item>
		<title>
		By: YourGene to assist with COVID-19 testing - UK Investor Magazine		</title>
		<link>https://ukinvestor.foxrobinson.com/novacyt-shares-jump-45-following-fda-approval-for-covid-19-tests/#comment-14930</link>

		<dc:creator><![CDATA[YourGene to assist with COVID-19 testing - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 01 Apr 2020 13:29:57 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=28210#comment-14930</guid>

					<description><![CDATA[[&#8230;] for contract manufacturing services for ‘part’ of a COVID-19 Test. The agreement is with a subsidiary of Novacyt (LON:NCYT) which recently recorded a £131m Mkt Cap as the shares doubled on announcements it’s diagnostic tests kits went into [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] for contract manufacturing services for ‘part’ of a COVID-19 Test. The agreement is with a subsidiary of Novacyt (LON:NCYT) which recently recorded a £131m Mkt Cap as the shares doubled on announcements it’s diagnostic tests kits went into [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Investors must consider the Enterprise Investment Scheme (EIS) to support the NHS and economic recovery - UK Investor Magazine		</title>
		<link>https://ukinvestor.foxrobinson.com/novacyt-shares-jump-45-following-fda-approval-for-covid-19-tests/#comment-14894</link>

		<dc:creator><![CDATA[Investors must consider the Enterprise Investment Scheme (EIS) to support the NHS and economic recovery - UK Investor Magazine]]></dc:creator>
		<pubDate>Fri, 27 Mar 2020 08:48:02 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=28210#comment-14894</guid>

					<description><![CDATA[[&#8230;] been a number of high profile products from listed companies helping the coronavirus crisis such as Novacyt&#8217;s COVID-19 testing kits but some of the real innovations may be unlocked in unlisted companies that could benefit from EIS [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] been a number of high profile products from listed companies helping the coronavirus crisis such as Novacyt&#8217;s COVID-19 testing kits but some of the real innovations may be unlocked in unlisted companies that could benefit from EIS [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
